Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9in vivo
Authors:
Open Access
- 28 March 2016
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (12) , 3341-3354
Abstract
To investigate whether the regulation of aquaporin 3 (AQP3) and AQP9 induced by Auphen and dibutyryl cAMP (dbcAMP) inhibits hepatic tumorigenesis. Expression of AQP3 and AQP9 was detected by Western blot, immunohistochemistry (IHC), and RT-PCR in HCC samples and paired non-cancerous liver tissue samples from 30 hepatocellular carcinoma (HCC) patients. A xenograft tumor model was used in vivo. Nine nude mice were divided into control, Auphen-treated, and dbcAMP-treated groups (n = 3 for each group). AQP3 and AQP9 protein expression after induction of xenograft tumors was detected by IHC and mRNA by RT-PCR analysis. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay and histological evaluation were used to detect apoptosis of tumor cells, and the concentration of serum α-fetoprotein (AFP) was measured using RT-PCR and an ELISA kit. The volumes and weights of tumors decreased significantly in the Auphen- and dbcAMP-treated mice compared with the control mice (P < 0.01). The levels of AQP3 were significantly lower in the Auphen treatment group, and levels of AQP9 were significantly higher in thedbcAMP treatment mice than in the control mice (P < 0.01). The reduction of AQP3 by Auphen and increase of AQP9 by dbcAMP in nude mice suppressed tumor growth of HCC, which resulted in reduced AFP levels in serum and tissues, and apoptosis of tumor cells in the Auphen- and dbcAMP-treated mice, when compared with control mice (P < 0.01). Compared with para-carcinoma tissues, AQP3 expression increased in tumor tissues whereas the expression of AQP9 decreased. By correlating clinicopathological and expression levels, we demonstrated that the expression of AQP3 and AQP9 was correlated with clinical progression of HCC and disease outcomes. AQP3 increases in HCC while AQP9 decreases. Regulation of AQP3 and AQP9 expression by Auphen and dbcAMP inhibits the development and growth of HCC.Keywords
This publication has 42 references indexed in Scilit:
- Prognostic Value of Combined Aquaporin 3 and Aquaporin 5 Overexpression in Hepatocellular CarcinomaBioMed Research International, 2013
- Targeting Aquaporin Function: Potent Inhibition of Aquaglyceroporin-3 by a Gold-Based CompoundPLOS ONE, 2012
- Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic studyJBIC Journal of Biological Inorganic Chemistry, 2009
- Altered aquaporin 9 expression and localization in human hepatocellular carcinomaHPB, 2009
- Aquaporins—new players in cancer biologyJournal of Molecular Medicine, 2008
- Aquaporins and cell migrationPflügers Archiv - European Journal of Physiology, 2007
- Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitisGut, 2007
- Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinomaCancer Letters, 2007
- Aquaporins and glycerol metabolismBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Appearance of Water Channels in Xenopus Oocytes Expressing Red Cell CHIP28 ProteinScience, 1992